openPR Logo
Press release

Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Highlighted key Growth Factor

01-23-2018 11:31 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Systemic Antibiotic-Sulfonamide Combination

Sulfonamides are a group of drugs that are derived from sulfanilamide, a sulfur containing compound. Sulfonamides are the most commonly used antibiotics around the world and have been in clinical use since 1968. Sulfonamides, also known as anti-metabolites and sulfa drugs act by inhibiting the folic acid synthesis pathway in a bacterial cell. These antibiotics are considered as selective targeted option since human do not synthesize folic acid, but a bacterial cell requires it for the synthesis of adenine and thiamine derivatives of its nucleic acid. These drugs are bacteriostatic in nature and are often utilized in the systemic treatment of acute, uncomplicated urinary tract infections and respiratory upper tract infections. With a broad spectrum of activity, these drugs are also utilized to treat various other bacterial infections like enteritis, chronic bronchitis in adults, otitis media in children and traveler’s diarrhea.

The leading drugs in this segment are sulfamethoxazole, sulfisomidine, sulfadiazine, sulfaisodimidine, sulfacetamide, sulfisoxazole, sulfasalazine, sulfadoxine and dichlorphenamide. One of the combination drugs available in this class is the sulfamethoxazole/trimethoprim combination which becomes bactericidal in action in contrast with the other sulfa drugs. Some of the key brands available in this class are Dapsone (diamino-diphenylsulfone) and Sepmax (sulfamethoxazole and trimethoprim) from GlaxoSmithKline plc; Blephamide(prednisolone and sulfacetamide) from Allergan, Inc. and Vasocidin (prednisolone and sulfacetamide) from Novartis AG.

Request Pre Book @ https://www.transparencymarketresearch.com/checkout.php?rep_id=12284<ype=S

Major growth drivers for the systemic antibiotic-sulfonamide combination market will include availability of large number of generics at affordable prices in emerging markets and increasing prevalence of various infectious diseases such as urinary tract and upper respiratory tract infections. These drivers are likely to push the volume sales of drugs of this class. Worldwide rise in elderly population is also expected to play a key role in driving the market growth as elderly populations is at high risk of developing various infections requiring systemic antibiotic-sulfonamide combination drugs for cure.

Geographically, the market for systemic antibiotic-sulfonamide combination pharmaceuticals has been segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). In North America and Europe, the market is characterized by market maturity and increasing penetration by generic manufacturers. Stringent regulatory guidelines pose a significant challenge before the growth of this market to some extent in these regions. However, the market may experience a significant growth on the introduction of new products during coming years. Asia-Pacific represents the most potential market for this segment and is expected to record the highest growth rate during the upcoming years. Some major factors expected to drive the systemic antibiotic-sulfonamide combination market growth in the region include, presence of large number of generic manufacturers in major Asian countries (especially in India and China), growing incidences of infectious diseases and emerging economies leading to increased purchasing power of the people belonging to this region. In addition, the region being a home for more than half of the world population is also likely to represent a large pool of patients with various infectious diseases that would consequently increase the uptake of sulfonamide class of drugs.

Report Details @ https://www.transparencymarketresearch.com/systemic-antibiotic-sulfonamide-combination-pharmaceuticals-market.html
Some of the major players engaged in the development, manufacturing and marketing of systemic antibiotic-sulfonamide combination drugs are GlaxoSmithKline plc, Allergan, Inc., Pfizer Ltd., Sanofi, Novartis AG, Bristol-Myers Squibb Company, Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and AstraZeneca plc. These players compete with each other in order to get competitive advantages over each others. In developing nations like India, China, Mexico and Brazil, they face intense competition from local manufactures that offer systemic antibiotic-sulfonamide combination drugs at relatively low prices.

Request Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12284

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Highlighted key Growth Factor here

News-ID: 913161 • Views: 143

More Releases from Transparency Market Research

Celandine Extract Market: Competitive Strategies And Forecasts to 2026
Celandine extract is a botanical extract derived from the greater celandine plant. The greater celandine plant belongs to the poppy family, which grows wild in Asia and Europe and has been introduced to North and South America widely. Celandine extract has been used as an herbal medicine for the treatment of gastrointestinal complaints and gallbladder issues. Celandine extract is also known to be a mild sedative and has been used
Cinnamon Extract Market Forecast and Segments, 2018 - 2026
Market Outlook: Cinnamon Extract Cinnamon extract is a form of spice derived from cinnamon the species of the inner bark of Cinnamomum tree. In the global cinnamon market, the demand for cinnamon extract is primarily increasing as a flavoring additive, cuisines, savory dishes, beverages, and various other food products. In addition, the demand for cinnamon extract is also high among personal care products owing to its medicinal benefits. In the global
Bitter Melon Extract Market is Expected to Register Lucrative Growth By 2026
Bitter Melon Extract: Market Outlook The bitter melon extract is the extract obtained from the bitter melon fruit that is grown widely in Asia, Africa, and the Caribbean. Due to the bitterness of the bitter melon extract, they are unpalatable for most of people. But there are significant medicinal advantages of the bitter melon extract, which is why they are grown so extensively. The fruit of bitter melon is extracted, concentrated,
Sandarac Gum Market Globally Expected to Drive Growth through 2026
Market outlook: Sandarac gum is defined as a colloidal gum which is shed by the sandarac trees that belongs to the cypress family. Sandarac gum is natively found in the regions of North Africa and Morocco where the production is relatively higher. Due to high suspension and colloidal properties, sandarac gum is utilized in preserving painting materials. Sandarac gum is highly aromatic in nature which enables its ample applications in manufacturing

All 5 Releases


More Releases for TMR

TMR Research
Global 3D Animation Market: Snapshot The evolution and introduction of three-dimensional (3D) animation has given the world of animation a new perspective. The process of creating 3D moving images in a digital space through objects or models has given these illusions depth. One of the most fundamental differences between 2D animation and 3D animation is the technique used for creating the images and the way they look. The global 3D animation
TMR
Various strategies are leveraged by success-hungry players in the global hyperbaric oxygen therapy devices market. One of them is the thrust on research and development to come up with new or better products. Their focus is on building cost-effective medical devices that would see greater uptake. Strategic partnerships are also being undertaken by them to diversify product portfolios and gain greater share. Further, companies are shifting their gaze to developing
Monolithic Ceramics Market Analysis : TMR
Transparency Market Research has published a new market report titled “Monolithic Ceramics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.” According to the report, the global monolithic ceramics market was valued at US$ 19.43 Bn in 2014 and is anticipated to reach US$ 36.64 Bn by 2023, expanding at a CAGR of 7.3% between 2015 and 2023. Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3158 Monolithic ceramics are
TMR - 3D Printing Materials Market by 2020
The global 3D printing materials market will exhibit a CAGR of 18.0% between 2014 and 2020. The market was valued at US$450 mn in 2013 and is expected to reach US$1.4 bn by the end of 2020, according to a research report released by Transparency Market Research. The report titled “3D Printing Materials - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020” is available for sale
Wax Market Analysis : TMR
A recent research report published by Transparency Market Research projects the global wax market to expand at a CAGR of 2.6% during the period between 2014 and 2020. The report, titled “Wax Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” estimates the global wax market to be worth US$8.98 bn by 2020. The overall market stood at a valuation of US$8.21 bn in 2013
Sulfone Polymers Market Analysis : TMR
Global Sulfone Polymers Market: Snapshot Several grades/varieties of sulfone polymers have gained vast applicability across a number of industries in the past few years. The relatively higher level of resistance wear and corrosion provided by these materials as compared to metals have increased their usage in medical devices and implants. Owing to their high transparency resistance, low weight, and high performance, the demand for sulfone polymers is also rising in the